Cargando…

Immunomodulatory therapies for COVID-19

PURPOSE: As COVID-19 disease progresses, the host inflammatory response contributes to hypoxemia and severe and critical illness. In these latter stages of disease, patients may benefit from immunomodulatory therapies to control the aberrant host inflammatory response. In this review, we provide an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathur, Poonam, Kottilil, Shyamasundaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381694/ https://www.ncbi.nlm.nih.gov/pubmed/35991665 http://dx.doi.org/10.3389/fmed.2022.921452

Ejemplares similares

Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
por: Mathur, Poonam, et al.
Publicado: (2018)

Oral Polio Vaccine to Protect Against COVID-19: Out of the Box Strategies?
por: Malave Sanchez, Melanie, et al.
Publicado: (2021)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

The influence of inflammation on cardiovascular disease in women
por: Kottilil, Sita, et al.
Publicado: (2022)

Immunomodulatory mechanisms of abatacept: A therapeutic strategy for COVID-19
por: Yang, Dinglong, et al.
Publicado: (2022)

Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus
por: Khanam, Arshi, et al.
Publicado: (2020)

2072. Of Mice and Men: HIV-induced CD38 expression on CD8+ T lymphocytes contributes to mitochondrial dysfunction and chronic inflammation despite antiretroviral therapy
por: Mathur, Poonam, et al.
Publicado: (2022)

Immunomodulatory Therapy Reduces the Severity of Placental Lesions in Chronic Histiocytic Intervillositis
por: Brady, Chloe A., et al.
Publicado: (2021)

Potential Use of Adjuvant Bacteriophage Therapy With Debridement, Antibiotics, and Implant Retention Surgery to Treat Chronic Prosthetic Joint Infections
por: Doub, James B, et al.
Publicado: (2021)

Pharmaco-Immunomodulatory Therapy in COVID-19
por: Rizk, John G., et al.
Publicado: (2020)

Abnormal brain diffusivity in participants with persistent neuropsychiatric symptoms after COVID-19
por: Liang, Huajun, et al.
Publicado: (2023)

Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection
por: Husson, Jennifer S., et al.
Publicado: (2017)

A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory/biologic therapy: recommendations should not differ between non-pregnant and pregnant individuals
por: Messas, Tassahil, et al.
Publicado: (2023)

Use of oral polio vaccine and the incidence of COVID-19 in the world
por: Habibzadeh, Farrokh, et al.
Publicado: (2022)

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Vrachatis, Dimitrios A., et al.
Publicado: (2020)

Ongoing oxidative stress in individuals with post-acute sequelae of COVID-19
por: Saleh, Muhammad G., et al.
Publicado: (2022)

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection
por: Price, Angie S., et al.
Publicado: (2022)

1067. Interferon-free Hepatitis C Treatment Increases Surrogates of Cardiovascular Disease Risk in Black Veterans
por: Mathur, Poonam, et al.
Publicado: (2020)

Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management
por: Khanam, Arshi, et al.
Publicado: (2021)

Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy
por: Ahodantin, James, et al.
Publicado: (2022)

Immunomodulatory Role of Capsular Polysaccharides Constituents of Cryptococcus neoformans
por: Decote-Ricardo, Debora, et al.
Publicado: (2019)

Immunomodulatory Effects of Heme Oxygenase-1 in Kidney Disease
por: Li, Yunlong, et al.
Publicado: (2021)

Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine
por: Ling, Jiawei, et al.
Publicado: (2022)

COVID-19 Infection Among Women in Iran Exposed vs Unexposed to Children Who Received Attenuated Poliovirus Used in Oral Polio Vaccine
por: Habibzadeh, Farrokh, et al.
Publicado: (2021)

Editorial: Immunomodulatory Approaches in Cardiovascular Diseases
por: Booz, George W., et al.
Publicado: (2022)

Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2020)

The impact of COVID-19 on kidney transplant care
por: Zhang, Chi, et al.
Publicado: (2023)

Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies
por: Pluijmert, Niek J., et al.
Publicado: (2021)

Advances in hepatitis B therapeutics
por: Soriano, Vicente, et al.
Publicado: (2020)

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes
por: Ammar, Lama A., et al.
Publicado: (2021)

Case report: Disseminated herpes simplex virus 1 infection and hemophagocytic lymphohistiocytosis after immunomodulatory therapy in a patient with coronavirus disease 2019
por: Mazzotta, Elvio, et al.
Publicado: (2022)

Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy
por: Pisoschi, Aurelia Magdalena, et al.
Publicado: (2022)

Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report
por: da Silva, Kátia Nunes, et al.
Publicado: (2021)

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
por: Alunno, Alessia, et al.
Publicado: (2021)

Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
por: Mansouri, Parvin, et al.
Publicado: (2021)

Changes in inflammatory and immune drivers in response to immunomodulatory therapies in COVID-19
por: Wang, Stephen Y., et al.
Publicado: (2020)

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021)

Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome
por: Casadó-Llombart, Sergi, et al.
Publicado: (2022)

CD38: an ecto-enzyme with functional diversity in T cells
por: Ghosh, Alip, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v7nhiudkuqi2j23odv86eah0s6